Newborn screening begins for Phenylketonuria (PKU) by public Health Ontario
Screening History
The timeline below takes you through the history of newborn screening in Ontario, Canada.
-
19651965
-
19781978
Congenital Hypothyroidism (CH) screening begins
-
2006April 4, 2006
Newborn screening moves from Public Health Ontario to Newborn Screening Ontario (NSO) at the Children's Hospital of Eastern Ontario (CHEO). Screening continues for PKU and CH, and begins for Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD).
-
2006August 8, 2006
Screening begins for 18 additional metabolic conditions, including other Fatty Acid Oxidation Defects (FAODs), Amino Acidemias (AAs), and Organic Acidemias (OAs)
-
2006November 24, 2006
Hemoglobinopathy (HbSS, HbSC, and Hbs/ß-thalassemia) screening begins
-
2007February 28, 2007
Screening begins for Biotinidase Deficiency and Galactosemia
-
2007May 14, 2007
Congenital Adrenal Hyperplasia (CAH) screening begins
-
2008April 7, 2008
Cystic Fibrosis (CF) screening begins
-
2013August 12, 2013
Severe Combined Immune Deficiency (SCID) screening begins
-
20172017
Screening for Critical Congenital Heart Disease (CCHD) begins
2019
Risk factor screening for Permanent Hearing Loss (PHL) (CMV and genetic risk factors) begins
2020
Screening for Spinal Muscular Atrophy (SMA) and Hurler disease (“Mucopolysaccharidosis type 1H” or “MPS1H”) begins
2022
Guanidinoacetate methyltransferase (GAMT) deficiency and Biliary Atresia (BA) screening begin
